BIOTRICITY INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOTRICITY INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $4.48M.
- BIOTRICITY INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- BIOTRICITY INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $119.28K.
- BIOTRICITY INC. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $0.00.
- BIOTRICITY INC. stock issued during period, value, new issues for fiscal 2026 was $4.60M.
- BIOTRICITY INC. stock issued during period, value, new issues for fiscal 2022 was $250.00K, a 95.66% decline from fiscal 2021.
- BIOTRICITY INC. stock issued during period, value, new issues for fiscal 2021 was $5.76M, a 20058.83% increase from fiscal 2020.
- BIOTRICITY INC. stock issued during period, value, new issues for fiscal 2020 was $28.57K, a 99.23% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $4.60M 10-K · filed 2026-07-14 | |
| 2025-03-31 | $4.60M 10-Q · filed 2026-08-19 | |
| 2024-03-31 | $4.48M derived: 10-Q 12 month − 10-Q/A 9 month · filed 2026-08-19 | $4.60M 10-Q · filed 2026-08-19 |
| 2023-12-31 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-02-20 | |
| 2023-09-30 | $119.28K 10-Q · filed 2024-11-14 | |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-29 | $250.00K 10-K · filed 2023-06-29 |
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | |
| 2021-09-30 | $250.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $5.76M 10-K · filed 2022-07-14 | |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-11-04 | $215.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $215.00K 10-Q/A · filed 2021-08-17 | $229.56K derived: sum of 4 quarters · filed 2021-08-17 |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-22 | $28.57K 10-K · filed 2021-06-22 |
| 2019-12-31 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $707.10K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $14.56K 10-Q · filed 2020-11-13 | $1.93M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $14.00K 10-Q · filed 2020-08-14 | $3.22M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $678.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-15 | $3.72M 10-K · filed 2020-07-15 |
| 2018-12-31 | $1.22M 10-Q · filed 2020-02-14 | |
| 2018-09-30 | $1.30M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $515.00K 10-Q · filed 2019-08-15 | |
| 2018-03-31 | $5.18M 10-K · filed 2019-07-16 | |
| 2015-11-30 | $0.00 10-Q · filed 2015-12-21 | |
| 2015-08-31 | $45.00K 10-K · filed 2016-04-13 | |
| 2014-11-30 | $0.00 10-Q · filed 2015-12-21 | |
| 2014-08-31 | $0.00 10-K · filed 2015-11-30 |